Innoviva Inc
NASDAQ:INVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innoviva Inc
NASDAQ:INVA
|
US |
Intrinsic Value
The intrinsic value of Innoviva Inc (INVA) under the Base Case is 22.256 USD per share.
Compared with the current market price of 21.355 USD, the stock appears
Undervalued by 4% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Innoviva Does
Innoviva is a healthcare royalty company. Its main business is owning rights to receive payments on medicines developed and sold by other companies, especially inhaled treatments for lung diseases. Instead of running a big drug sales force, Innoviva sits further up the value chain and collects income when partner products sell well.
- Headquarters
- United States of America US
- Employees
- 159
- IPO date
- Oct 5, 2004
Revenue & Expenses Breakdown
Innoviva Inc
Earnings Waterfall
Innoviva Inc
The intrinsic value for Innoviva Inc (INVA) under the Base Case is 22.256 USD.
Compared with the current market price of 21.355 USD, the stock appears Undervalued by 4% .